https://www.selleckchem.com/pr....oducts/bi-1015550.ht
Patient-specific quality assurance (QA) is very important in radiotherapy, especially for patients with highly conformed treatment plans like VMAT plans. Traditional QA protocols for these plans are time-consuming reducing considerably the time available for patient treatments. In this work, a new MC-based secondary dose check software (SciMoCa) is evaluated and benchmarked against well-established TPS (Monaco and Pinnacle ) by means of treatment plans and dose measurements. Fifty VMAT plans have been computed using same calculation
Like
Comment
Share
